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Abstract
Objectives: Several recent studies report the presence of a specific EEG pattern named Thalamocortical Dysrhythmia (TCD)
in patients with severe chronic neurogenic pain. This is of major interest since so far no neuroscientific indicator of chronic
pain could be identified. We investigated whether a TCD-like pattern could be found in patients with moderate chronic back
pain, and we compared patients with neuropathic and non-neuropathic pain components. We furthermore assessed the
presence of psychopathology and the degree of psychological functioning and examined whether the strength of the TCD-
related EEG markers is correlated with psychological symptoms and pain ratings.
Design: Controlled clinical trial with age and sex matched healthy controls.
Methods: Spontaneous EEG was recorded in 37 back pain patients and 37 healthy controls.
Results: We were not able to observe a statistically significant TCD effect in the EEG data of the whole patient group, but a
subsample of patients with evidence for root damage showed a trend in this direction. Pain patients showed markedly
increased psychopathology. In addition, patients’ ratings of pain intensity within the last 1 to 12 months showed strong
correlations with EEG power, while psychopathology was correlated to the peak frequency.
Conclusion: Out of several possible interpretations the most likely conclusion is that only patients with severe pain as well
as root lesions with consecutive thalamic deafferentation develop the typical TCD pattern. Our primary method of defining
‘neuropathic pain’ could not reliably determine if such a deafferentation was present. Nevertheless the analysis of a specific
subsample as well as correlations between pain ratings, psychopathology and EEG power and peak frequency give some
support to the TCD concept.
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Introduction
Chronic pain is one of the most frequent chronic diseases. The
largest subgroup of chronic pain conditions is lower back pain
which is often considered as the one condition causing the largest
financial damage to the economy in terms of treatment and work
days lost [1]. The life time prevalence for chronic back pain in
Germany is estimated to be 24% for men and 30% for women
[2]. Accordingly there are many interdisciplinary efforts to
investigate the genesis and maintenance of chronic pain. While
there is growing knowledge on the peripheral and spinal
neuronal mechanism of pain chronification processes there is
only limited understanding of central nervous changes in chronic
pain [3].
Considerable information on the central neural mechanisms of
chronic severe neurogenic (or neuropathic) pain has been obtained
from studies on specific thalamocortical patterns [4–10]. Accord-
ing to this approach there is a relationship between neurogenic
pain and thalamocortical dysfunctional rhythmic activity. This
pattern originates in the presence, due to thalamic deafferentation,
of low threshold calcium spikes (LTS) with a mean interburst
discharge rate of 4 Hz at the limit between the delta and theta
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recordings in the thalamus of patients with neurogenic pain [11–
14]. It was furthermore demonstrated, using quantitative EEG
analyses, that this dysfunctional pattern results in an increased and
shifted mode of cortical processing, providing thus a non-invasive
neural marker of chronic pain [5,10]. This overly accentuated
neural rhythmicity was termed Thalamocortical Dysrhythmia
(TCD) [5,15]. In 2008 Sarnthein and Jeanmonod [8] published a
paper where they report about simultaneous recording of local
field potentials in the medial thalamus and surface EEG in 10
patients during surgery. Patients showed the presence of a theta
peak in the EEG spectrum as well as a theta peak in the local field
potential spectrum with a maximum coherence in this frequency
range.
In order to describe the specific EEG pattern of this TCD
Sarnthein et al. [7] compared the EEG spectral activity during rest
of 15 patients with severe neurogenic pain with 15 matched
healthy controls. Patients showed two marked differences in their
power spectra. Overall power was consistently higher in patients
over the whole frequency range, mainly in the theta and beta
domains. Furthermore their peak of the power spectral density was
significantly shifted toward lower frequencies. Patients underwent
neurosurgery with a therapeutic lesion in the medial thalamus.
From a subgroup of seven patients postoperative EEG was
recorded at 3 and 12 months after surgery. All but one patient
reported strong pain relief (median 95%) and showed a reduced
power compared to before surgery. The power spectrum after 12
months was very similar to that of healthy controls and also
exhibited an increased frequency of the peak power. In a similar
study by Stern et al. [10] the low frequency EEG overactivity
could be localized in cortical regions associated with pain
processing [see also 16].
Based on these findings it can be assumed that the presence of
TCD can be detected in the surface EEG and that this pattern (i.e.
increased overall power, power peak decreased towards theta
range) may be a marker of severe chronic neuropathic pain. Since
TCD seems to be related to the perpetuation and chronification of
pain we wondered if this specific EEG pattern could also be found
in a wider population of chronic pain patients.
We were furthermore interested in psychological correlates of
chronic back pain and whether these correlates were also related
to the EEG patterns under consideration. It is well known that
chronic pain and especially chronic back pain is associated with
psychological distress [17–19] in general and depression in
particular [20–22]. This is most likely due to a self-maintaining
process of pain and illness behaviour, less activity and social
withdrawal which then results in psychological distress and has a
negative effect on pain experience.
In the current investigation we replicated the study of
Sarnthein et al. [7] on a different, i.e. more general sample
[23]. Thereby we had the following for objectives: (i) to assess
whether a TCD-related EEG pattern generalizes to patients with
only moderate chronic pain and (ii) also to patients with chronic
pain which is not due to a neuropathic origin while all other
methodological aspect were duplicated from [7]. In order to have
a more clearly defined sample of chronic pain patients than in the
predecessor studies we restricted our sample to chronic back pain
patients and compared them with a sample sex and aged matched
healthy controls. We furthermore assessed (iii) psychopathology-
related symptoms and psychological functioning in order to
evaluate psychological impairment in relation to chronic back
pain. Additionally we aimed to assess (iv) whether EEG power
and peak frequency is related to psychological symptoms as well
as pain ratings.
Methods
1. Design
We performed a controlled clinical trial with age and sex matched
healthy persons as controls. The EEG spectral density as well as a set
of questionnaires assessing psychological symptoms and psychological
functioning of a sample of 37 patients with chronic back pain was
compared with a sample of 37 healthy sex and age matched controls.
Data within the patient group were split into patient with neuropathic
pain vs. non neuropathic pain and compared to each other. The
protocol for this trial and supporting CONSORT checklist are
available as supporting information; see Checklist S1 and Protocol S1.
2. Patients
Inclusion criteria for our study were (1) chronic back pain of
least 1 year, (2) daily complaints about back pain, (3) an average
rating of at least 5 for the average pain of the last 12 months on a
VAS ranging from 0=no pain at all to 10=worst pain possible (4)
age 18 to 70 years and (5) command of German language.
Exclusion criteria were (1) the presence of psychiatric conditions
including substance dependence, (2) immune suppressive treat-
ment, (3) life threatening diseases, (4) participation in other clinical
trials. Patients were recruited between July 2008 and December
2008 by public announcements and via pain specialists, neurol-
ogists and orthopaedists as well as through the Interdisciplinary
Pain Unit of the University Medical Center. Patients underwent
telephone screening before being invited to an intake interview to
the Department of Environmental Health Sciences were all
measurements took place. They were examined by an MD to
determine inclusion and exclusion criteria before being included in
the trial. Patients were offered participation in a behavioural
intervention free of costs after EEG measurement.
Healthy controls were recruited via public announcements.
They had to be healthy and were not allowed to suffer from any
pain. Controls were remunerated with 20 Euros for their
participation in the EEG recording.
The trial was approved by the University Medical Center ethic’s
committee (please see Supporting Information for full letter) and
was registered before start of recruitment at www.clinicaltrials.gov
NCT00744575. All patients and controls gave written informed
consent.
2.1 Sub samples. The sample of chronic pain patients was
furthermore divided into two sub-samples. This was done by an
MD with special training in chronic pain management. Patients
were classified as either having pain of neuropathic origin (or not).
Assessment took place according to the definition published by
Treede et al. [24] which was also taken over by the International
Association for the Study of Pain (IASP). They define neuropathic
pain as ‘‘Pain arising as a direct consequence of a lesion or disease
affecting the somatosensory system’’ [24, p. 1630].
Sample Size. Sample size was determined on the basis of the
predecessor study, which found significant results with N=15
patients. Since we wanted to split our sample in two subsamples we
recruited with N=37 more than twice as many patients in order to
arrive at least at the same statistical power for each subsample than
in the original study.
3. Measurements
Questionnaires
Patient filled in the following questionnaires:
1. EuroQol Quality of Life Questionnaire EQ-5D [25]. This is a simple
5 item questionnaire for health related quality of life (HRQoL).
In addition there is a VAS regarding the general health state.
Thalamocortical Dysrhytmia in Back Pain
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form of the SCL 90-R a symptom check list functioning as
screening instrument for psychopathology.
3. Hospital Anxiety and Depression Scale HADS [28,29] a 14 items
screening instrument for anxiety and depression disorders.
4. Pain Perception Scale PPS [30] A questionnaire measuring pain
perception with the two subscales sensory and affective pain,
with 14 and 10 items, respectively.
5. Chronic Pain Grade CPG [31]. This scale assesses the severity of
chronic pain problems. It provides a set of several visual
analogue scales (VAS) assessing pain intensity during the last
three months. We added modified versions of this VAS in
order to also assess average pain during the last 4 weeks and
during the last 12 months.
6. Questions on Life Satisfaction QLS [32]. This is a 32 item German
questionnaire assessing generic as well as health related life
satisfaction on 8 different dimensions.
7. The general intake form of the Interdisciplinary Pain Unit. This is
an 18 page intake questionnaire especially designed for pain
patients which collects information on sociodemographics,
medication, pain localisation and prior treatments.
Healthy control participants had only to fill in BSI, EQ-5D,
QLS, and HADS.
4. EEG recording
EEG was recorded (bandpass filtered 0–200 Hz; A/D rate
1000 Hz) with 72 channel amplifier (Quickamp, MES, Munich,
Germany) according to the international 10/20 system, from 60
electrode sites distributed throughout the whole head of the
participants. The ActiCap System (MES, Munich, Germany), that
includes a cap with active electrodes was used. Diagonal EOG was
recorded bipolarly from above and below the right eye to exclude
trials contaminated with eye movements from further analysis.
The ground electrode was placed in the left mastoid and the
output EEG data was average referenced.
Electrode impedances were kept under 5 kV. All measurements
took place between 8 and 12 am in order to avoid sleepiness. All
participants had to abstain from caffeine on the day of
measurement since caffeine is known to influence theta activity
[33]. EEG assessment took place in a sound and electromagnet-
ically attenuated chamber in the neurophysiology lab of the
department. During the experimental session, we recorded
5 minutes of EEG with eyes closed and 5 minutes with open eyes
while the participant was sitting on a chair in a sound and
electromagnetically shielded, dimly lit chamber. Only the data of
the eyes closed condition was used for the subsequent analyses.
5. Data processing
All data analyes were performed with the commercial software
Brain Vision Analyser 2.0 (MES, Munich, Germany) and custom
scripts in MatLab (MathWorks, USA). Artefacts due to ocular
movement were first eliminated applying the Gratton & Coles
algorithm, as implemented in Brain Vision Analyzer. Remaining
EEG segments contaminated with eye movements, EMG or other
artefacts of technical origin were rejected off-line by visual
inspection. EEG channels with residual artefacts (mainly periph-
eral sites in the temporal and frontal regions) were excluded from
further analysis. Data were filtered with a bandpass filter
(Butterworth Zero Phase Filter 1–30 Hz, slope 48 dB/oct) and
segmented into 4 seconds epochs (with 2 s overlapping), allowing
for a frequency resolution of 0.25 Hz. For each participant, 100
free-of artefact segments were included in further analyses. At this
point two different analyses were conducted in parallel: In the first
one, a discrete 4000 sample Fast Fourier Transformation (FFT)
was computed for each segment (conceptual replication of
Sarntheim et al., [7]. In the second analysis, previous to the
FFT calculation, EEG epochs were first transformed into the
reference-free current source density distribution (CSD), which
reflects the underlying cortical activity and removes nearly all
volume conduction effects [34]. The CSD algorithm was estimated
using the spherical spline interpolation method [35] as imple-
mented in BrainVision Analyzer 2.0. These two different
procedures will be further referred as replication and CSD analysis.
In both cases, topographic distribution of power spectral density
(PSD) was obtained by averaging across all 100 epochs. Given that
PSD from all channels were similar, we averaged the log-
transformed spectra across all channels for each participant.
Grand-average power spectral density was then computed across
subjects for comparing different sub-groups (i.e. patients vs.
controls, neuropathic pain vs. non-neuropathic etc.).
6. Data Analysis and Statistics
Similar to the study of Sarntheim et al. [7], the frequency of the
dominant peak (peak frequency) and the log-transformed PSD values
at this frequency (peak power) was determined for each participant,
in order to assess differences between the subgroups. Since for
some participants the power spectral density did not show only one
clearly dominating peak but looked broadly distributed within the
frequency range of interest (4–12 Hz), we defined two other
indices to grasp the overall EEG activity and its dominant
frequency within this frequency range. First, the mean peak
frequency and according standard deviation were computed across
all participants. Next the lower and upper limits of a frequency-
based ROI were defined by 6 two standard deviations of the
mean peak frequency. This resulted in two ROIs of 7.34 to
12.43 Hz for the replication and 7.07 to 12.43 Hz for the CSD
analysis respectively. Additionally for each participant and type of
analysis, the overall power was computed as the log-transformed sum
of all PSD values within the empirically defined ROIs. In addition,
we calculated for each ROI its centre of gravity CoG, which is the
frequency at which the whole EEG power is split into two equal
parts. This CoG splits the ROI into two parts with the same
overall power. By this procedure we arrived at four different
indices (peak frequency, peak power, centre of gravity and overall power)
which were then passed on to the subsequent statistical analysis.
All statistics were calculated with SPSS for Windows 15.0 (SPSS
Inc, Chicago, Il). We tested all variables comparing between
patients and controls for normal distribution by the Kolmogorv
Smirnoff Test. If they proved to be normally distributed we
applied the t-test for independent samples otherwise we used the
non parametric Mann-Whitney U-Test. For the correlation of
questionnaire and pain rating data with EEG parameters we
applied the non parametric Spearman’s rho. As an effect sizes
measure for group differences Cohen’s d was applied [36].
Results
1. Participants
On the basis of telephone screenings 38 patients were invited for
intake examination and were included as well as and 40 healthy
controls of same age (63 yrs) and sex. Eighteen patients were
classified as having neuropathic pain and 19 as non neuropathic.
One patient and 3 control persons had to be excluded from the
analysis (see figure 1 for flow chart on recruitment). Basic sample
characteristics can be seen from table 1. An overview on
diagnoses, pain duration and classification as well as medication
Thalamocortical Dysrhytmia in Back Pain
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informations).
2. Questionnaire Data
2.1 HrQoL, Life Satisfaction and Psychological
Symptoms. Questionnaires on HrQoL and life satisfaction as
well as the two screening scales regarding psychological symptoms
were filled in by both groups. In table 2 health related parameters
of the two samples are compared and tested for significant
differences.
Patients and controls showed marked differences in all
psychological variables. For thirteen out of fifteen subscales these
were significant. Effect sizes range from medium to very large.
2.2 Pain Specific Questionnaire Measures. Pain specific
questionnaires measures were filled in by the patient group only
(N=37). We assessed pain ratings by VAS (0 to 10) and pain
perception by the Pain Perception Scale. As can be seen in table 3
the neuropathic and non-neuropathic subgroups showed
significant differences regarding their pain perception but
reported pain intensities in the same range.
3. EEG Results
Figure 2 shows a descriptive display of the spontaneous EEG
activity measured over all electrodes (2b) in the two groups with
reference to the respective power bands (theta, alpha, beta) as well
as a topographic display of the power distribution (2a).
3.1 Predefined analyses. For the comparison between
patients and controls we used as described in the Methods section
two different frequency indices, i.e. Peak Frequency and Center of
Gravity (CoG). Furthermore we assessed the specific power at the
peak frequency (Peak Power) as well as within the defined ROI
(Overall Power). Analyses of EEG spectral data were based on surface
EEG values (conceptual replication of [7] ) as well as based on the
underlying CSD activity. Thus we arrived at eight relevant indices.
Complete data for the comparison of patients with controls can be
found in table 4.
As can be seen in table 4 and figure 3a unlike in the Sarnthein et
al. study no difference could be found between the patient and the
control group regarding their peak power and peak frequency.
Similarly, our analysis based on additional indices did not yield
any significant difference between patients and controls. Differ-
ences between groups were very small and in opposite to the
expected direction.
The topographical power distribution in figure 2a clearly shows
the strongest power is in the occipital region. In order to perform a
more specific analysis we defined a region of interest (ROI) for
parieto-occipital area. The ROI consisted of nine electrodes (Oz,
O1, O2, Pz, P1, P2, POz, PO3, PO4). The resulting power density
distribution for this ROI only can be seen in figure 2c, the
combined chart depicting Power and Peak Frequency simulta-
neously in figure 3b. Obviously there was no difference between
the all electrodes and the ROI approach.
We repeated the same analysis for the two subgroups of
neuropathic and non-neuropathic patients. Both samples were
compared with their respective controls for significant differences
in the eight EEG indices. We did not find any significant results in
Figure 1. CONSORT flow chart on patient recruitment.
doi:10.1371/journal.pone.0031138.g001
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pathic patients with controls ranged from p=.29 to .83, for non
neuropathic patients from p=.10 to .95 respectively.
3.2 Post-hoc analyses. In order to find out whether our
failure to replicate the findings by Sarnthein was due to the
extension of our sample to patients with moderate chronic pain we
selected a subsample with severe pain from all patients. Fourteen
patients reporting a pain intensity $7 were included in this sub-
sample, 8 out of them with neuropathic and 6 with non
neuropathic pain. In this subsample six of the eight indices (all
four CSD indices as well as surface EEG Overall Power and Peak
Power) showed differences in the expected direction but none of
these differences reached significance, p-values ranged from
p=.23 to .69). The according effect sized for these differences
ranged from d=0.15 to 0.47.
Another possibility why our replication failed may be the fact
that only a limited number of patients in our sample fulfilled the
necessary conditions for a root lesion resulting in TCD. Thus, one
of us (JD) assessed patients’ records for the following criteria: (a)
ICD diagnosis either M51.2 (Other specified intervertebral disc
displacement: Lumbago due to displacement of intervertebral disc)
or M54.4 (Lumbago with sciatica), and (b) irradiation of the pain
and/or somatosensory deficits in the lower extremity. The goal
was here to ascertain more tightly the presence of neuropathic
pain mechanisms, i.e. of a root damage as the source of thalamic
deafferentation. Eight patients fulfilled these criteria and were
compared to their respective controls in an exploratory post-hoc
analysis. None of the eight EEG indicators yielded a significant
difference (p-values ranging from .09 to .87), but contrary to the
whole sample, patients in this subsample had higher power values
than their respective controls. The effect sizes for the four power
indices were in the range from d=0.20 to d=0.44. The findings
for the frequency parameters were inconsistent with two times
patients having lower frequencies and two times controls. These 8
patients tended, however, to cluster in the top left part of Figure 3c
and 3d, speaking for a correlation trend with higher EEG power
and lower peak frequency.
4. Correlations with EEG parameters
In order to see whether there is a relationship between
subjective questionnaire data and EEG parameters we calculated
the respective correlation coefficients (see table 5). We report only
those questionnaire scales for which significant correlations were
found. Additionally table 6 shows correlation coefficients between
EEG parameters and all pain ratings.
All significant correlations found between EEG parameters and
psychological variables were only with frequency indices. All
significant correlations were in the same direction associating
larger psychopathology with lower frequency values or better
psychological functioning with higher frequency respectively. On
the other hand all significant correlations between pain ratings and
EEG were only with power indices. Here higher pain ratings
correlated consistently positive with EEG power values. Highest
correlations were found for averaged pain ratings of the last four
weeks, three months and 12 months but not for pain at the
moment of EEG recording.
Discussion
In our comparison of subjective and objective data of chronic
back pain patients with sex and age matched controls we see most
clearly strong differences in psychopathology and psychological
functioning between the two groups. Patients scored significantly
worse regarding psychological symptoms in general (BSI, Global
Severity Index) as well as on seven of the nine specific subscales
with the other two approaching significance. Effect sizes ranged
from 0.41 to 0.98 and are all medium or large in size. In the
Table 1. Sociodemographic data of the patients and controls.
Patients Controls
N3 7 3 7
Age (SD) 50.0 (10.21) 49.8 (10.82)
Sex (m/f) 9/28 9/28
Education Level
9 years 6 1
11 years/GCSE 15 9
A-level/college entry level 15 26
missing 1 1
Family Status
married 15 13
married, living sep. 0 1
widow 1 0
divorced 7 7
Single 13 14
missing 1 1
doi:10.1371/journal.pone.0031138.t001
Table 2. Means, standard deviations, significance and effect
size Cohen’s d for health related parameters comparing back
pain patient with healthy controls.
Patients Controls p Effect size d
HrQoL N=36
c N=37
EQ 5D VAS scale 54.8 (19.8) 84.0 (11.0) ,.001
a 1.82
Symptom List BSI N=36
c N=37
GSI 0.67 (0.51) 0.29 (0.33) ,.001
a 0.88
somatization 0.85
d (0.66) 0.34 (0.41) ,.001
a 0.93
obsessive-comp. 1.05 (0.69) 0.50 (0.40) .001
a 0.98
depression 0.66 (0.72) 0.20 (0.36) .001
a 0.81
anxiety 0.68 (0.62) 0.29 (0.45) .001
a 0.72
phobic anxiety 0.51 (0.75) 0.14 (0.26) .002
a 0.66
interpersonal sensitivity 0.78 (0.81) 0.42 (0.49) .02
b 0.54
hostility 0.53 (0.48) 0.29 (0.46) .04
b 0.51
paranoid ideation 0.59 (0.70) 0.33 (0.49) .08
b 0.43
psychoticism 0.34 (0.46) 0.19 (0.23) .08
b 0.41
Life Satisfaction QLS N=37 N=37
generic 29.8
c (36.4) 53.3 (31.6) .008
a 0.69
health related 26.5 (34.4) 74.7 (33.2) ,.001
a 1.43
HADS N=37 N=37
anxiety 7.92 (4.16) 3.68 (3.00) ,.001
a 1.17
depression 7.54 (4.36) 2.52 (2.42) ,.001
a 1.42
aMann-Whitney-U-Test,
bt-Test for independent samples.
cN=36, one patient excluded due to too many missing items.
dN=34.
doi:10.1371/journal.pone.0031138.t002
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the effect sizes were even higher with 1.17 (anxiety) and 1.42
(depression). This finding was supported by the more generic
measures of HrQoL and life satisfaction. Here the differences were
still larger with the topmost value being close to two standard
deviations (1.82, HrQoL). It is evident form our findings that the
continuous back pain present in these patients is accompanied by a
severe reduction in quality of life, life satisfaction as well as
increased psychopathology compared to a healthy control group.
This is in line with findings of other investigators, e.g. for
psychological distress measured by the SCL 90-R (which is the
longer version of the BSI scale applied here) in relation to chronic
back pain [17–19].
Regarding their pain intensity patients reported medium to
strong values. The inclusion criteria requested an average pain
rating during the last months of at least 5 on a VAS from 0 to 10.
On the day of the measurement patients showed a rather
moderate rating with a mean of 4.5. Average pain ratings during
the last four weeks, last three months and last twelve months were
all between 5 and 6. We split our sample into the two subgroups of
18 pain patients with neuropathic origin and 19 patients with non-
neuropathic origin. These subgroups showed no differences
regarding their pain intensity but differences regarding their pain
perception. Neuropathic patients reported more intense pain
perceptions in the sensory and in the affective domain. This makes
sense on the background that neuropathic pain can also be
diagnosed on the basis of pain sensations which are markedly
different on several sensory dimensions [37]. In our case the
diagnosis was based on a definition also adopted by the IASP [24]
and the differences in pain perception give support to this
procedure. This definition however does not separate damages of
small nerve branches in different tissues like capsules, ligaments or
muscles from root damage, which is the only damage able to give
rise to the ischialgic neuropathic deafferentation syndrome,
typically seen after ‘‘failed back surgery’’. As shown by a post-
hoc subsample analysis, only 8 patients fulfilled criteria for an at
least probable root lesion, indicating that 10 patients were selected
wrongly as being neuropathic by the above-mentioned definition.
Regarding the EEG results we were not able to replicate the
findings by [7]. The whole patient group neither showed a
significant increase in power nor a slowed dominant frequency.
This was true for our conceptual replication as well as for our EEG
analysis based on computation of the current source density
(CSD), which has the advantage of reflecting the underlying
cortical activity. For both analysis methods as well as for two ways
of calculating the relevant power or frequency variables we found
only very slight non-significant differences which were all in the
opposite direction of the original findings. However, when the
sample was restricted to the fourteen most severe pain patients the
indices pointed in the expected direction but did not reach
significance. And when the sample was restricted to the eight
neuropathic patients selected as having root damage and thus
susceptible to elicit TCD, all power indices pointed into the
expected direction.
How can these only slight effects be explained? There are
several possibilities we can think of.
1. Small sample
It might be that our sample was too small to detect significant
differences in the relevant EEG parameters. While this cannot be
ruled out, we do not consider this interpretation as very likely. We
had 37 patients and 37 controls compared to 15 patients and 15
controls in the forerunner study. However it might be interesting
to note that Sarnthein et al. did not present results of inference
statistics on comparing the means of frequency and power
variables as we did. Rather they performed a discrimination
analysis where they could show that on the basis of the two
variables peak frequency and peak height 87% of all participants could
be correctly classified as patients or controls. The fact that the
power spectra of patients and controls showed clear differences
can also be seen from the graphical display in Sarnthein et al.
(2006, fig. 1 & 2). In contrast the same graph of our data (fig. 2)
shows no differentiation of the two groups at all.
2. Back pain does not result in TCD
Another interpretation is that back pain is due to a different type
of mechanism than the pain types reported in the predecessor
study. Out of the 15 patients in the Sarnthein et al. study none
suffered from back pain. Pain locations were mainly trigeminal
and leg. Back pain is due to nociceptive (or somatogenic)
mechanisms elicited by increased nociceptor activation in
peripheral tissues. This is indeed the opposite of a neuropathic
dynamic induced by reduced thalamic activation (or deafferenta-
tion) and causing the EEG pattern described as TCD. This study
Table 3. Means and standard deviations of pain specific questionnaires in the sample chronic back pain patients, and the two sub
samples ‘‘neuropathic pain’’ and ‘‘non neuropathic pain’’.
All patients (N=37
a) neuropathic (N=18
a) non neuropathic (N=19
a) Sign. p
PPS
affective 33.2 (10.06)
N=35
36.7 (10.34) 29.5 (8.56)
N=17
.03
sensory 19.6 (6.29)
N=36
22.1 (6.40) 17.2 (5.28)
N=18
.02
Pain VAS
present moment 4.46 (2.19) 4.89 (2.22) 4.05 (2.15) .25
av. last four weeks 5.72 (2.07) 5.83 (2.21) 5.63 (1.98) .77
av. last three months 5.35 (1.62) 5.33 (1.78) 5.37 (1.50) .95
average twelve months 5.61 (1.82)
N=36
5.86 (1.78) 5.36 (1.89)
N=18
.42
P-values reflect a comparison of the means of the sub-samples by a t-test for independent samples.
aif not stated otherwise.
doi:10.1371/journal.pone.0031138.t003
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nociceptive mechanisms do not give rise to TCD, or possibly only
to thalamocortical overactivities too discrete to show up with the
applied techniques.
3. Only very strong pain elicits statistically significant EEG
overactivities, i.e. a significant TCD
Another difference in comparison to the forerunner study was
that patients in the Sarnthein et al. study had much stronger pain,
which lead them to surgical treatment. Mean pain intensity was
rated 6.9 (SD=1.18, median=6.5, no time interval reported)
compared to 5.7 (SD=2.07, median=5.0, mean pain intensity
during the last four weeks) in our study. This difference may be
even a bit masked due to the pain medications many patients took
in both studies. In the Sarnthein study 10 out of 15 patients (67%)
took either benzodiazepines, antiepileptics, antidepressants, opi-
ates or a combination of them; in our study the rate for the same
medications was only 43%. To test for this hypothesis we drew a
subsample of 14 patients with a pain rating of $7 (average over
the last four weeks). We still did not find any significant differences
compared to healthy controls but now the direction of the effect
changed for 6 out of 8 EEG variables into the hypothesized
direction with small to medium effect sizes. This is at least a hint
pointing into the direction of a TCD pattern.
4. An initial, TCD-inducing event (root lesion) does not
guarantee the long term maintenance of TCD
In our study, only 8 patients suffered from pain syndromes
compatible with root damage and thus fulfilling the criteria of
Sarnthein et al. The modes of selection in the two studies were very
different: in Sarnthein et al., patients were specifically selected for
root damage as the source of chronic therapy-resistant neuropathic
syndromes and at the exclusion of dominant nociceptive situations,
which were either absent or at best coupled to the neuropathic
Figure 2. Topographic maps (top view) and average power spectra. The topographical distribution of EEG power (2a) had a maximum at
parieto-occipital electrodes for the dominant power peak (9.5 Hz) in both patient and control groups. Note that differences in mean power spectrum
are minimal between patient (black) and control group (grey) across all electrodes (2b) and within the ROI (2c) for all the frequency ranges theta,
alpha and beta (delimited by horizontal grey bars). The ROI included electrodes Oz, O1, O2, Pz, P1, P2 and POz, PO3, PO4. In this top view only
electrodes Pz, P1, P2 and POz, PO3, PO4 (marked with black spots) are observed.
doi:10.1371/journal.pone.0031138.g002
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possibility was excluded that the neuropathic pain had become
secondary or even irrelevant as time passed, replaced by nociceptive
or psychogenic components. In our study, there exists indeed the
possibility that an initial neuropathic dynamics, due to root lesion
and causing TCD at the onset of pain, decreased/disappeared over
time, leaving the place for and the lead to a chronification of their
back pain by one or both of these components. Interestingly, the
selected subsample of eight patients with most likely root lesion and
thus TCD showed, similar to the subsample of patients with
stronger pain, small differences for their power indices in the
expected direction (larger power in patients) which was not true for
the full sample. In addition, these patients tended to cluster in the
topleftpart ofFigure3cand3d,correlating with higherEEGpower
and lower peak frequency. However, one has to keep in mind that
this is an exploratory post-hoc analysis.
According to the last three interpretations, it can be assumed that
a majority of the patients in our study had either not severe enough
and/or non-neuropathic pain components. Because of this, they
could not elicit as a group a statistically significant TCD pattern.
We found medium size but highly significant correlations
between the individual pain rating and the EEG parameters as
well as between the subjective variables and the EEG patterns.
Regarding pain intensity we only found significant correlations
with power indices but not with frequency indices. In contrast
questionnaire data correlated only significantly with frequency
indices but not with power related variables.
The correlations with pain intensity were strongest for average
pain intensity during the last 1 to 12 months but were weaker and
mostly not significant with pain intensity during the day of
measurement. This finding clearly indicates that there is a
relationship with continued pain experience and EEG power.
Since the correlation was smallest for the pain present during the
measurement it can be assumed that the increase in power is not
due to actual pain experience but due to a chronification process
due to persistent pain as this is hypothesized in TCD. The
correlation coefficients of r=.39–.50 demonstrate that 15% to
25% of the variance in EEG power is due to pain experience in the
last year. This finding indicates that severe chronic pain in a group
of patients having predominantly nociceptive and/or psychogenic
components results in larger EEG power. To explain this finding,
we have evidence [38] that psychological factors can indeed be at
the source of a TCD development, which is localized bilaterally
over large prefrontal paralimbic and associative cortical areas.
Interestingly and in the same direction, the shift of the peak
frequency was correlated with some of the self-reported data. Here
all significant correlations also pointed into the expected direction
showing a shift towards smaller frequency with an increase in
psychopathology or a reduction in life satisfaction. These findings
are quite likely not due to chance. For the whole set of EEG
frequency variables correlated with subjective indices we can
expect by chance 3.4 significant correlations (a=.05, four EEG
indices, 17 subscales) while we find seven. Here it is also interesting
that we do find correlations mainly for life satisfaction (QLZ) but
not for strength of psychopathological symptoms as e.g. reflected
by GSI. Additionally there is a significant correlation with affective
pain perception. In order to assess if these results could also be
explained by the fact that chronic pain is correlated with poorer
life satisfaction and larger psychopathology as reflected in table 2
we tried to regress EEG variables by both pain ratings and
psychological variables in some exploratory analyses. None of
these models could explain more than what was already reflected
in the correlation tables. Pain ratings could not explain additional
variance in frequency parameters and psychological variables did
not enter regression models for power indices (data not reported).
In conclusion we were not able to generalize the findings of a
TCD-related, statistically significant EEG pattern to patients with
moderate back pain. The number of patients suffering from an
ongoing and dominant neuropathic dynamics was too small to
replicate the significant data from Sarnthein et al. Nevertheless
three of our findings are in accordance with the TCD concept.
This is the fact that the EEG patterns in our patient group are
more in accordance with TCD predictions in patients with severe
pain ratings than in patients with moderate pain, as well as in
patients with thalamic deafferentation and ongoing dominant
neuropathic dynamics. Moreover there is a strong correlation
between pain intensity during the last 1 to 12 months and EEG
power but not with present pain. Thus the EEG parameters
Table 4. Means and standard deviations for the four main EEG indices and for two analyses methods for patients and matched
controls.
mean (SD) Sign. p d
patients
(N=37)
controls
(N=37)
Surface EEG
Peak Freq (replication) [Hz] 10.07 (1.06) 9.64 (1.06) .09 0.41
Peak Power (replication) [mV
2/Hz]* 10.68 (6.38) 11.53 (5.62) .55 20.14
CoG [Hz] 9.86 (.49) 9.72 (.49) .24 0.29
Overall Power [mV
2/Hz]* 17.82 (5.24) 18.82 (4.86) .40 20.20
CSD
Peak Freq. [Hz] 10.11 (1.18) 9.78 (.89) .18 0.32
Peak Power [mV
2/Hz]* 28.53 (6.26) 28.82 (4.93) .83 20.05
CoG [Hz] 9.89 (.47) 9.88 (.41) .88 0.02
Overall Power [mV
2/Hz]* 36.15 (5.16) 36.33 (4.06) .59 20.12
P-values reflect a comparison of the means of the sub-samples by a t-test for independent samples. ‘replication’ indicates variables which were also applied in the
predecessor study.
*=log-transformed.
doi:10.1371/journal.pone.0031138.t004
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e31138Figure 3. Scatterplot of EEG indices Peak Power and Peak Frequency (Replication) for individual participants. Left panel (replication):
Values for patient (crosses) and control groups (circles) across all electrodes (3a) and within the ROI (3b). Mean values in the patient and control groups
are shown in grey color. Right panel: Mean values for neuropathic patients fulfilling the necessary conditions for root lesion (diamonds) and non-
neuropathic patients (crosses) across all electrodes (3c) and within the ROI (3d). The ROI included electrodes Oz, O1, O2, Pz, P1, P2 and POz, PO3, PO4.
doi:10.1371/journal.pone.0031138.g003
Table 5. Correlation coefficients between EEG parameters and questionnaire data.
BSI obs.-comp. QLS generic QLS health PPS affective
Frequency Indices
Replic. CoG 2.04 .13 .24 2.09
Replic. Peak Freq. 2.30 .44** .42* 2.36*
CSD CoG 2.23 .28 .38* 2.19
CSD Peak Freq. 2.45** .39* .48** 2.36*
Power Indices
Repl. Overall Power .25 2.16 2.20 .22
Repl. Peak Power .20 2.17 2.21 .16
CSD Overall Power .22 2.14 2.15 .16
CSD Peak Power .20 2.18 2.20 .19
Only scales with significant correlations are reported.
*p,.05,
**p,.01. In the BSI and PPS higher values indicate more symptoms or stronger pain perception. In the QLS higher values indicate larger life satisfaction.
doi:10.1371/journal.pone.0031138.t005
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relationship with strong and also persistent pain experience. While
our findings on one hand support the TCD concept, they also
demonstrate that these specific changes in the EEG cannot be used
as a marker for chronic pain as a whole, and that a distinction,
which is anyway of primary clinical relevance, must be done
between neuropathic, nociceptive and psychogenic mechanisms.
However, whether EEG-based TCD-analyses are of use for any of
these subgroups was beyond the scope of our study.
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